Grading Systems for CTA Rejection Proposals and Prospects David E. Kleiner, M.D., Ph.D. National Cancer Institute.

Slides:



Advertisements
Similar presentations
Significance of the total i-score
Advertisements

Christopher Berlin // März 2015 A Histologic Scoring System for Prognosis of Patients with Alcoholic Hepatitis Altamirano et.al., Gastroenterology 2014.
CLEAR CELL ACANTHOMA CASE REPORT Floarea Sărac, Alin Meseşan, Constanţa Turda University of Oradea, Faculty of Medicine and Pharmacy, Dermatology Department,
Endothelial Cell Changes as an Indicator for Upcoming Allograft Rejection Following Descemet Membrane Endothelial Keratoplasty Jack Parker Jr, MD; Lamis.
THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.
The Value of Zero-Hour Implantation Biopsies Volker Nickeleit Nephropathology Laboratory, Department of Pathology The University of North Carolina, Chapel.
PATHOLOGIC DIAGNOSIS OF ANTIBODY-MEDIATED REJECTION (AMR) Histopathologic findings Immunopathologic findings Immunohistochemistry on paraffin sections.
Banff 2001 Liver Group Discussions. 1. Rejection 2.Centrilobular (zone 3) inflammatory lesions 3.Changes in late post-transplant biopsies Banff
Slide 1PUBLICATIONS Racusen/Solez meeting report for AJT. Racusen/Solez meeting report for AJT. Manuscript on antibody-mediated rejection. Manuscript on.
Pancreas Transplant Pathology: Controversial Lesions Lois J. Arend PhD, MD University of Cincinnati Department of Pathology.
Pathology Journal Reading
Sum Scores & Components’ Scores Chronic Scores Acute Rejection Scores Lillian W. Gaber University of Tennessee.
Calcineurin Inhibitor Toxicity In Kidney Allograft Protocol Biopsies Neeraja Kambham M.D. Stanford University.
The Banff Classification: Slide Seminar Kim Solez, M.D.
GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed? Cinthia B. Drachenberg, M.D. University of Maryland School of Medicine Baltimore MD.
HISTOPATHOLOGY OF PANCREAS TRANSPLANTATION
Sum Scores and Scores of Individual Components in Clinical Practice and Clinical Trials Lillian W. Gaber University of Tennessee.
Draft guideline for scoring and reporting interstitial fibrosis Working Group on Fibrosis Banff 09 Colvin RB Banff 2009.
BACKGROUND ON PANCREAS HISTOLOGICAL FINDINGS: University of Maryland experience John C. Papadimitriou, M.D.,Ph.D. Professor of Pathology.
NEOPLASIA (Malignant Tumors)
Case Study 62 Kenneth Clark, MD. Question 1 This is a 32-year-old woman with progressive distortion of taste and smell. After seeing her primary care.
Endoscopic Ultrasound in Chronic Pancreatitis
Satoshi Kobayashi, Japan AJG,1993 Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Renal Transplantation for HIV/HCV Co-infected Patients Solid Organ Transplantation and People With HIV: Ethics and Policy Conference David Oldach & Robert.
North Carolina STARI Introduction Barbara Johnson, PhD –CDC, Foothills Campus, 3150 Rampart Road, Fort Collins, CO –Phone:
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
Pathology of Kidney and the Urinary tract
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
Patient Information - Viral Hepatitis B (HBV)
Severe vascular lesions and poor functional outcome
Polyomavirus nephropathy: updated Helmut Hopfer, Basel, Switzerland.
Postoperative Visual Acuity in Patients With Fuchs Dystrophy Undergoing Descemet Membrane–Stripping Automated Endothelial Keratoplasty: Correlation With.
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
UK National Renal Transplant EQA Scheme Ian Roberts Department of Cellular Pathology, Oxford Radcliffe Hospitals The National Renal Transplant EQA Scheme.
CH. 5 GOODMAN. CH.5  “Many conditions and diseases seen in the rehabilitation setting can affect multiple organs or systems.”
OUTCOME MEASURES IN PsA: IMMUNOHISTOLOGY Oliver FitzGerald.
Hepatitis. Hepatitis * Definition: Hepatitis is necro-inflammatory liver disease characterized by the presence of inflammatory cells in in the portal.
David E. Kleiner, M.D., Ph.D Staff Surgical Pathologist, Laboratory of Pathology, NCI (1992-Present) Hepatic Pathologist –Collaborations with Dr. Jay Hoofnagle.
LyP Three histologic types of LyP have been described: types A, B and C. D ?
Pathology of Renal Transplantation
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
EXANTHEMIC DRUG ERUPTIONS
ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAY IN CADAVER KIDNEY
Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E
Dolianitis C, Kelly J Victorian Melanoma Service,
In The Name Of GOD.
Fundamentals of Anatomy & Physiology
Pathology Of Explanted Cryopreserved Allograft Heart Valves: Comparison With Aortic Valves From Orthotopic Heart Transplants  Richard N. Mitchell, MD,
T. N. Nikonenko, A. V. Trailin and A. S. Nikonenko
Chapter 12 Liver Transplantation 1
Chapter 12 Liver Transplantation 1
a b c d e Supplemental figure 4
Chapter 12 Liver Transplantation 1
Drug induced complications; can we do more?
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter.
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the horse  C.W. McIlwraith, D.D. Frisbie, C.E.
Localized involutional lipoatrophy with epidermal and dermal changes
Exploring longitudinal associations of histologically assessed inflammation with symptoms and radiographic damage in knee osteoarthritis: combined results.
Donor skin allograft survival after bone marrow transplantation: Case report and systematic review of the literature☆  Teresa Nunez-Villaveiran, Patrick.
Update on Graft versus Host Disease
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
Dr: Hamed Al-Ghamdi CONSULTANT VASCULAR SURGERY
Volume 61, Issue 4, Pages (April 2002)
A, full thickness muscle biopsy from the right upper arm demonstrating eosinophilic fasciitis. A, full thickness muscle biopsy from the right upper arm.
Clinical, dermatoscopical and histopathological correlation of atypical actinic keratoses ID21905 Alise Balcere1, Raimonds Karls, Māris Sperga1, Māra Rone.
Table 1. Histological disease score
Volume 5, Issue 7, Pages (July 2019)
Presentation transcript:

Grading Systems for CTA Rejection Proposals and Prospects David E. Kleiner, M.D., Ph.D. National Cancer Institute

Grading system philosophy and choices of grading systems Review of published grading system criteria for CTA acute rejection Comparison of existing systems looking for common themes Where do we go from here? Setting the Stage

What Are the Goals in Creating a Grading System? Stratification for treatment/protocol entry –Minimum hepatic fibrosis for HCV therapy Prognostication –Cancer Staging and Grading Structured pathology data collection –NASH-CRN Feature Scoring System

Some Definitions Stage – Stratification of the level of progress of a disease to its final end-point (Clinical Tool) Grade – Stratification of the severity of a disease or disease feature at a particular point in time (Clinical Tool) Scoring – the assignment of quantitative or semi-quantitative values to individual disease features (Research Tool) It is usually possible for therapeutic intervention to improve the Grade of a disease but it is usually difficult or impossible to improve the Stage of a disease

Time Loss of Function (Stage) Cirrhosis Organ Failure Onset of Disease Death The apparent rate may or may not be a good predictor of progression Rate (Grade)

Types of Grading Systems Tiered Systems –Each grade is differentiated by the addition of a new lesion –Banff Renal Acute Cellular Rejection Grade I vs II Progressive Severity Systems –Gradual worsening of one or more features with (arbitrary) thresholds –Banff Renal Acute Cellular Rejection Borderline vs Ia vs Ib Composite Score Systems –Grade is a summation of scores of individual features –Hepatitis inflammation grading

Tiered Grading Systems InflammationEpithelial InjuryVascular Injury Grade Grade 2 + (any)+- Grade 3 + (any) + Advantages: Easy to use, Probably better reproducibility Disadvantages: Doesn’t account well for variation in severity of features, especially when features seem inappropriately mild or negative

Progressive Severity System InflammationEpithelial InjuryVascular Injury Grade Grade 2 ++ Grade Advantages: Better system when features generally vary in parallel. Natural relationship to scoring individual features Disadvantages: Need to define thresholds for each feature -> decreases reproducibility. Difficulties assigning grade if features are out of sync with one another.

Composite Score System InflammationEpithelial InjuryVascular Injury Score Range 0-3 Advantages: Most sophisticated system. Accounts well for individual variation between features. Relates well to scoring systems. Better for clinical trials Disadvantages: Threshold problems. Implied weighting of features, therefore requires advanced knowledge of relative importance of features Sum the individual scores: 0: Grade 0; 1-3: Grade 1; 4-6: Grade 2; 7-9: Grade 3

Published Systems for Grading CTA Rejection The Pathology of Full Thickness Cadaver Skin Transplant for Large Abdominal Defects –Bejarano et al., Am. J. Surg. Pathol. 28: ; 2004 Steroid- and ATG-Resistant Rejection After Double Forearm Transplantation Responds to Campath-1H –Schneeberger et al., Am. J. Transplant 4: ; 2004 Pathological Score for the Evaluation of Allograft Rejection in Human Hand (Composite Tissue) Allotransplantation –Kanitakis et al., Eur J. Dermatol. 15: 235-8; 2005 Composite Tissue Allotransplantation: Classification of Clinical Acute Skin Rejection –Cendales et al., Transplantation 81:418-22; 2006

Abdominal wall transplantation 9 patients (5 adults, 4 children), 10 transplants 22 specimens (17 punch biopsies, 3 graft excisions, 2 post-mortem) Blind categorization (3 pathologists) of multiple histologic features related to inflammation, epidermal changes and stromal changes Features were analyzed with respect to an overall clinico-pathologic determination of the presence of rejection

Histologic Associations with Rejection Non-Rejection (mean/mode) N = 9 Rejection (mean/mode) N = 13 p No. infiltrated vessels0.1 (0.2%)12.7 (35%)0.017 Intensity of Perivascular Infiltrates Location of perivascular infiltratesNoneUpper dermis Small Lymphocytes Large Lymphocytes Eosinophils Endothelial Plumping Spongiosis

No Rejection Grade 0 No perivascular infitrates. Indeterminate for Rejection Grade 1 < 10% of vessels with perivascular infiltrates, no spongiosis, eosinophils, large lymphocytes, epidermal infiltrates or stromal inflammation. Mild Rejection Grade % of vessels with perivascular infiltrates, +/- mild spongiosis, eosinophils. No epidermal infiltrates, stromal infiltrates or large lymphocytes. Moderate Rejection Grade 3 >50% of vessels with perivascular infiltrates +/- epidermal/stromal inflammation, eosinophils, endothelial plumping, large lymphocytes. No dyskeratosis. Severe Rejection Grade 4 >50% of vessels with perivascular infiltrates with dyskeratosis, heavier lymphocytic infiltrates in the epidermis, moderate to severe spongiosis, stomal inflammation extending to basal layer

Case report of 41 M with double forearm transplantation Grading system presented based on clinical experience with prior rejection episodes and on published literature of CTA rejection Reported 2 Grade I rejections that were steroid- responsive and one Grade IVa rejection that was steroid-resistant and ATG-resistant but responded to Campath-1H Follow-up biopsies confirmed resolution of infiltrates

Minimal Rejection Grade I Perivascular lymphocytic and eosinophilic infiltrates Mild Rejection Grade II Additional interface reaction in epidermis and/or adnexal structures Moderate Rejection Grade III Diffuse lymphocytic infiltration of epidermis and dermis Marked Rejection Grade IVa Necrosis of single keratinocytes and focal dermal-epidermal separation Marked Rejection Grade IVb Necrosis and loss of the epidermis

Hand/Forearm Transplants 6 patients (all M), 33.8 yrs (22-48) 89 skin biopsies (punch or scalpel) Biopsies reviewed for a variety of epidermal, adnexal, inflammatory and vascular changes Immunoperoxidase staining for lymphocyte phenotype, HLA, mast cells Grading based on biopsy review, grouping similar biopsies together into 5 grades

No Rejection Grade 0 Normal or very low density infiltrates around a few vessels Mild Rejection Grade I Mild dermal lymphocytic infiltrate forming perivascular cuffs in upper and occasionally mid-dermis. The epidermis is unaffected. Moderate Rejection Grade II Moderately dense dermal infiltrate, perivascular and interstitially between collagen bundles, +/- mild degree of epidermal exocytosis, spongiosis. No necrotic keratinocytes Severe Rejection Grade III Dense lymphocytic infiltrate around blood vessels in upper, mid, lower dermis and eccrine sweat glands. Band-like infiltrate in papillary dermis with lichenoid epidermal changes, spongiosis, exocytosis, variable epidermal apoptosis Very Severe Rejection Grade IV Pandermal inflammation with large cuffs of lymphocytes, variable epidermal thickness with areas of necrosis, thinning, hyperplasia, basal cell vacuolization, epidermal apoptosis

Forearm transplantation 2 patients, 11 biopsies Biopsies were ranked by overall severity of changes and grouped into categories to set definitions Interobserver agreement tested on grading 18 additional biopsies from abdominal wall transplants

Nonspecific Changes Grade 0 No or only mild lymphocytic infiltration, no involvement of adnexa or epidermis Mild Rejection Grade 1 Superficial perivascular inflammation in upper dermis, no involvement of epidermis Moderate Rejection Grade 2 Features of Grade 1 plus inflammatory infiltration of adnexal structures Severe Rejection Grade 3 Bandlike superficial dermal infiltrate with more continuous involvement of the epidermis, mid and deep dermal perivascular infiltrate Necrotizing Rejection Grade 4 Grade 3 with necrosis of epidermis or other tissues

Common Themes Perivascular lymphocytic infiltrates become progressively more intense and involve more vessels with increasing grades Inflammation extends to involve dermal stroma, epidermis (including DEJ), adnexa at moderate to marked grades Epidermal apoptosis/necrosis only at higher grades All tiered grading systems with implied worsening inflammation with increasing grade

Nominal Grade ProposalPerivascularDermal Inf Epidermal/ Adnexal Apoptosis/ Dysker. Necrosis / / Proposal 1 st author: 1. Bejarano, 2. Schneeberger, 3. Kanitakis, 4. Cendales Grades from None/Non-specific to Mild/Moderate

Nominal Grade ProposalPerivascularDermal Inf Epidermal/ Adnexal Apoptosis/ Dysker. Necrosis / Proposal 1 st author: 1. Bejarano, 2. Schneeberger, 3. Kanitakis, 4. Cendales Grades from Moderate to Very Severe

Approximate Grade Equivalences First Author BejaranoSchneebergerKanitakisCendales a 4b44

Conclusions and Challenges There is already substantial agreement on basic grade stratification for acute rejection Histologic features of rejection (especially at mild grades) are also seen in a large variety of non-rejection pathologies Published experience using pathology grading in prospective studies is very limited Future refinements may require prospective systematic evaluation of biopsy features, similar to other developed rejection classification systems We should consider defining scoring thresholds for scaling individual features (inflammation, epidermal injury etc.)